Biochemical markers of bone turnover and prediction of hip bone loss in older women: the study of osteoporotic fractures.

PubWeight™: 1.05‹?› | Rank: Top 15%

🔗 View Article (PMID 10457273)

Published in J Bone Miner Res on August 01, 1999

Authors

D C Bauer1, P M Sklarin, K L Stone, D M Black, M C Nevitt, K E Ensrud, C D Arnaud, H K Genant, P Garnero, P D Delmas, H Lawaetz, S R Cummings

Author Affiliations

1: Department of Medicine, University of California, San Francisco, San Francisco, California 94105, USA.

Associated clinical trials:

Texture Analysis for Postmenopausal Osteoporosis | NCT00145977

Articles citing this

Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int (2010) 3.36

Biochemical markers of bone turnover: potential use in the investigation and management of postmenopausal osteoporosis. Osteoporos Int (2008) 1.50

Age-dependent effects of atorvastatin on biochemical bone turnover markers: a randomized controlled trial in postmenopausal women. Osteoporos Int (2004) 1.39

Bone turnover markers: understanding their value in clinical trials and clinical practice. Osteoporos Int (2009) 1.37

An update on biomarkers of bone turnover and their utility in biomedical research and clinical practice. Eur J Clin Pharmacol (2006) 1.20

Biochemical markers of bone turnover, hip bone loss, and fracture in older men: the MrOS study. J Bone Miner Res (2009) 1.13

Reference database of biochemical markers of bone turnover for the Japanese female population. Japanese Population-based Osteoporosis (JPOS) Study. Osteoporos Int (2004) 0.99

Effects of a structured weight-bearing exercise program on bone metabolism among breast cancer survivors: a feasibility trial. Clin Breast Cancer (2010) 0.94

Prediction of bone loss using biochemical markers of bone turnover. Osteoporos Int (2007) 0.94

The evaluation of bone mineral density in patients with nonalcoholic fatty liver disease. Wien Klin Wochenschr (2012) 0.89

Effects of HIV infection and antiretroviral therapy with ritonavir on induction of osteoclast-like cells in postmenopausal women. Osteoporos Int (2010) 0.89

Reference intervals of bone turnover markers determined by using their curve-fitting valley for adult females in China. Osteoporos Int (2013) 0.88

Optimal use of vitamin D when treating osteoporosis. Curr Osteoporos Rep (2011) 0.88

Bone and the perimenopause. Obstet Gynecol Clin North Am (2011) 0.84

Consumption of a high calcium mineral water lowers biochemical indices of bone remodeling in postmenopausal women with low calcium intake. Osteoporos Int (2005) 0.84

Remarkable increase in lumbar spine bone mineral density and amelioration in biochemical markers of bone turnover after parathyroidectomy in elderly patients with primary hyperparathyroidism: a 5-year follow-up study. J Bone Miner Metab (2007) 0.83

Bone loss. Epidemiology of bone loss. Arthritis Res (2000) 0.82

Biochemical markers for bone turnover predict risk of vertebral fractures in postmenopausal women over 10 years: the Japanese Population-based Osteoporosis (JPOS) Cohort Study. Osteoporos Int (2012) 0.81

On genetic studies of bone loss. J Bone Miner Res (2006) 0.80

Bone turnover in elderly men: relationships to change in bone mineral density. BMC Musculoskelet Disord (2007) 0.78

Clinical relevance of changes in bone metabolism in inflammatory bowel disease. World J Gastroenterol (2010) 0.78

[The common occurrence of osteoarthritis and osteoporosis and the value of markers of bone turnover]. Z Rheumatol (2005) 0.77

Vitamin D, osteoprotegerin/receptor activator of nuclear factor-kappaB ligand (OPG/RANKL) and inflammation with alendronate treatment in HIV-infected patients with reduced bone mineral density. HIV Med (2015) 0.77

Prediction of changes in bone mineral density in postmenopausal women treated with once-weekly bisphosphonates. J Clin Endocrinol Metab (2009) 0.77

Associations of 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D With Bone Mineral Density, Bone Mineral Density Change, and Incident Nonvertebral Fracture. J Bone Miner Res (2015) 0.77

Serum tartrate-resistant acid phosphatase 5b in monitoring bisphosphonate treatment with clodronate: a comparison with urinary N-terminal telopeptide of type I collagen and serum type I procollagen amino-terminal propeptide. Osteoporos Int (2004) 0.77

Evaluation of markers of bone turnover during lactation in African-Americans: a comparison with Caucasian lactation. J Clin Endocrinol Metab (2012) 0.76

Age-related bone turnover markers and osteoporotic risk in native Chinese women. BMC Endocr Disord (2014) 0.75

Urinary N-telopeptide and Rate of Bone Loss Over the Menopause Transition and Early Postmenopause. J Bone Miner Res (2016) 0.75

Bone Turnover Markers in the Diagnosis and Monitoring of Metabolic Bone Disease. Clin Chem (2016) 0.75

Bone turnover markers are correlated with quantitative ultrasound of the calcaneus: 5-year longitudinal data. Osteoporos Int (2008) 0.75

Articles by these authors

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med (2001) 16.81

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet (1996) 13.20

Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med (1995) 13.01

Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med (1992) 12.89

Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA (1999) 11.23

Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med (2000) 11.12

Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res (1993) 10.98

Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med (1992) 9.86

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA (1999) 9.71

Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group. Lancet (1993) 9.34

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group. JAMA (1999) 9.05

Whole-Organ Magnetic Resonance Imaging Score (WORMS) of the knee in osteoarthritis. Osteoarthritis Cartilage (2004) 8.50

Epidemiology of osteoporosis and osteoporotic fractures. Epidemiol Rev (1985) 7.40

Appendicular bone density and age predict hip fracture in women. The Study of Osteoporotic Fractures Research Group. JAMA (1990) 6.25

Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst (2003) 6.20

Risk factors for recurrent nonsyncopal falls. A prospective study. JAMA (1989) 5.93

Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int (2005) 5.54

European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int (2008) 5.27

Accurate assessment of precision errors: how to measure the reproducibility of bone densitometry techniques. Osteoporos Int (1995) 5.22

A meta-analysis of previous fracture and subsequent fracture risk. Bone (2004) 4.92

Forgetting falls. The limited accuracy of recall of falls in the elderly. J Am Geriatr Soc (1988) 4.61

Vertebral fractures and mortality in older women: a prospective study. Study of Osteoporotic Fractures Research Group. Arch Intern Med (1999) 4.53

Dietary supplementation in elderly patients with fractured neck of the femur. Lancet (1990) 4.47

Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group. N Engl J Med (1998) 4.38

Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. N Engl J Med (1990) 4.10

Urinary incontinence: does it increase risk for falls and fractures? Study of Osteoporotic Fractures Research Group. J Am Geriatr Soc (2000) 4.05

Older women with diabetes have an increased risk of fracture: a prospective study. J Clin Endocrinol Metab (2001) 4.03

Measuring higher level physical function in well-functioning older adults: expanding familiar approaches in the Health ABC study. J Gerontol A Biol Sci Med Sci (2001) 4.01

Comparison of fixed-flexion positioning with fluoroscopic semi-flexed positioning for quantifying radiographic joint-space width in the knee: test-retest reproducibility. Skeletal Radiol (2003) 3.93

Closing in on a breast cancer gene on chromosome 17q. Am J Hum Genet (1992) 3.89

Continuing screening mammography in women aged 70 to 79 years: impact on life expectancy and cost-effectiveness. JAMA (1999) 3.82

Risk factors for injurious falls: a prospective study. J Gerontol (1991) 3.79

Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis. N Engl J Med (1990) 3.76

Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group. J Clin Endocrinol Metab (2000) 3.68

Radioimmunoassay of human parathyroid hormone in serum. J Clin Invest (1971) 3.67

Type of fall and risk of hip and wrist fractures: the study of osteoporotic fractures. The Study of Osteoporotic Fractures Research Group. J Am Geriatr Soc (1993) 3.55

Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int (2010) 3.36

Do we need to change the WHO definition of osteoporosis? Osteoporos Int (2000) 3.35

Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapy. Am J Med (1993) 3.23

Phenylalanines that are conserved among several RNA-binding proteins form part of a nucleic acid-binding pocket in the A1 heterogeneous nuclear ribonucleoprotein. J Biol Chem (1988) 3.16

The association of radiographically detected vertebral fractures with back pain and function: a prospective study. Ann Intern Med (1998) 3.13

Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures. Study of Osteoporotic Fractures Research Group. J Bone Miner Res (1999) 3.08

Secular trends in the incidence of hip and other osteoporotic fractures. Osteoporos Int (2011) 3.04

Physical performance measures in aging research. J Gerontol (1989) 2.86

Serum bone Gla-protein: a specific marker for bone formation in postmenopausal osteoporosis. Lancet (1984) 2.85

Ultrasonographic heel measurements to predict hip fracture in elderly women: the EPIDOS prospective study. Lancet (1996) 2.83

Smoking, alcohol, and neuromuscular and physical function of older women. Study of Osteoporotic Fractures Research Group. JAMA (1994) 2.82

Combined calcium and vitamin D3 supplementation in elderly women: confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: the Decalyos II study. Osteoporos Int (2002) 2.82

Contribution of vertebral deformities to chronic back pain and disability. The Study of Osteoporotic Fractures Research Group. J Bone Miner Res (1992) 2.82

Cognitive decline in women in relation to non-protein-bound oestradiol concentrations. Lancet (2000) 2.82

Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group. Arch Intern Med (2000) 2.81

Prevalent vertebral deformities predict mortality and hospitalization in older women with low bone mass. Fracture Intervention Trial Research Group. J Am Geriatr Soc (2000) 2.80

Simple measurement of femoral geometry predicts hip fracture: the study of osteoporotic fractures. J Bone Miner Res (1993) 2.78

A high ratio of dietary animal to vegetable protein increases the rate of bone loss and the risk of fracture in postmenopausal women. Study of Osteoporotic Fractures Research Group. Am J Clin Nutr (2001) 2.76

Current use of bisphosphonates in oncology. International Bone and Cancer Study Group. J Clin Oncol (1998) 2.73

Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int (1999) 2.70

How many joints in the hands and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis? Arthritis Rheum (1985) 2.68

Factors associated with appendicular bone mass in older women. The Study of Osteoporotic Fractures Research Group. Ann Intern Med (1993) 2.65

Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study. J Bone Miner Res (1996) 2.61

Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women. BMJ (1994) 2.61

Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res (1996) 2.59

Estrogen replacement therapy and fractures in older women. Study of Osteoporotic Fractures Research Group. Ann Intern Med (1995) 2.58

Frizzled-related protein variants are risk factors for hip osteoarthritis. Arthritis Rheum (2006) 2.57

Bone mineral density and risk of breast cancer in older women: the study of osteoporotic fractures. Study of Osteoporotic Fractures Research Group. JAMA (1996) 2.53

Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial. Bone (2003) 2.51

Radiographic osteoarthritis of the hip and bone mineral density. The Study of Osteoporotic Fractures Research Group. Arthritis Rheum (1995) 2.51

Broadband ultrasound attenuation predicts fractures strongly and independently of densitometry in older women. A prospective study. Study of Osteoporotic Fractures Research Group. Arch Intern Med (1997) 2.50